Oxidative stress and human diseases: origin, link, measurement, mechanisms and biomarkers
Food and Drug Administration (FDA) Consumer Updates on GLP-1 Receptor Agonist Safety Mandates, Approved Semaglutide Clinical Guidance, and Public Health Alerts (USA Gov)
Wegovy could make history again Wegovy made history this year when it slashed the risk of serious heart problems by 20% in people with obesity and heart disease in a late-stage trial
Cardiovascular safety of antidiabetic medications has received increasing attention since 2008 and here we summarize the recent updates from both clinical trials and preclinical experiments on the cardiovascular outcomes of this class of glucose-lowering drugs
Methylene Blue's journey traces back to the 1800s when it gained recognition for its effectiveness in treating cyanide poisoning
Months 18 and Beyond: Maintaining Your Results After 18 months, youll have options for maintaining your results, depending on your bodys needs and your goals